Xeris Biopharma Holdings (XERS) Times Interest Earned (2020 - 2026)
Xeris Biopharma Holdings' (XERS) quarterly Times Interest Earned came in at $0.92 in Q1 2026, up 356.18% YoY from $0.2 in Q1 2025, and down 60.68% on a QoQ basis from $2.33 in Q4 2025.
Xeris Biopharma Holdings (XERS) Times Interest Earned (2020 - 2026) Analysis & Trends
Xeris Biopharma Holdings (XERS) has 7 years of Times Interest Earned data on file, last reported at $0.92 in Q1 2026.
- Quarterly Times Interest Earned rose 356.18% year-over-year to $0.92 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.15 (up 259.63% YoY) and the FY2025 annual result came in at $0.58, up 441.03% from the prior year.
- Times Interest Earned eased to $0.92 in Q1 2026, from $2.33 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $2.33 in Q4 2025 to a low of -$4.79 in Q4 2022.
- A 5-year average of -$0.86 and a median of -$0.95 in 2024 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2023 — Times Interest Earned sank 660.24% — and 2025, when it soared 735.68%.
- Tracing XERS's Times Interest Earned over 5 years: stood at -$4.79 in 2022, then soared by 70.7% to -$1.4 in 2023, then jumped by 119.88% to $0.28 in 2024, then surged by 735.68% to $2.33 in 2025, then tumbled by 60.68% to $0.92 in 2026.
- The last three Times Interest Earned figures came in at $0.92 (Q1 2026), $2.33 (Q4 2025), and $0.78 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Xeris Biopharma Holdings | 1.51 Bn | 1.39 Bn | 79.59 Mn | 0.74 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.08 |
| Mar 31, 2026 | 0.92 |
| Dec 31, 2025 | 2.33 |
| Sep 30, 2025 | 0.78 |
| Jun 30, 2025 | 0.15 |
| Mar 31, 2025 | -0.36 |
| Dec 31, 2024 | 0.28 |
| Sep 30, 2024 | -1.49 |
| Jun 30, 2024 | -0.95 |
| Mar 31, 2024 | -1.65 |
| Dec 31, 2023 | -1.40 |
| Sep 30, 2023 | -0.57 |
| Jun 30, 2023 | -1.85 |
| Mar 31, 2023 | -1.35 |
| Dec 31, 2022 | -4.79 |
| Sep 30, 2022 | -1.82 |
| Jun 30, 2022 | -0.24 |
| Mar 31, 2022 | -2.68 |
| Dec 31, 2021 | -26.58 |
| Sep 30, 2021 | -13.53 |